Strikingly, knockout of SNAI2 was able to completely block CML development in a BCR-ABL transgenic mouse model, suggesting a key role for SNAI2 expression downstream of BCR-ABL (97). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.